These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 18476469)

  • 1. [Chemotherapy activity and pharmacokinetics of the fluoroquinolones generics Ofloxacin-PhPO and Pefloxacin-genova].
    Ptitsina SN; Bobrov VI; Borisov MM
    Antibiot Khimioter; 2007; 52(6):13-6. PubMed ID: 18476469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Excretion of fluoroquinolones into saliva].
    Kelentey BA; Kelentey BJ; Fekete I; Kozma J
    Fogorv Sz; 1995 Sep; 88(9):293-7. PubMed ID: 8522025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ketoprofen (NSAID) on the pharmacokinetics of pefloxacin and ofloxacin in healthy volunteers.
    Fillastre JP; Leroy A; Borsa-Lebas F; Etienne I; Gy C; Humbert G
    Drugs Exp Clin Res; 1992; 18(11-12):487-92. PubMed ID: 1308475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of ketoprofen on the pharmacokinetics of pefloxacin and ofloxacin.
    Fillastre JP; Leroy A; Borsa-Lebas F; Etienne I; Gy C; Humbert G
    J Antimicrob Chemother; 1993 May; 31(5):805-6. PubMed ID: 8335511
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of fluoroquinolones in hepatic failure.
    Montay G; Gaillot J
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():61-7. PubMed ID: 2258353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diffusion of fluoroquinolones in the aqueous humor and crystalline lens].
    Lafaix C; Salvanet A; Fisch A; Forestier F; Montay G; Meulemans A
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):768-71. PubMed ID: 3309812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of fluoroquinolones].
    Iakovlev VP
    Antibiot Khimioter; 1993 Jun; 38(6):66-78. PubMed ID: 8166571
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of ketoprofen on the pharmacokinetics of two fluoroquinolones in males].
    Leroy A; Fillastre JP; Borsa-Lebas F; Etienne I; Gy C; Humbert G
    Pathol Biol (Paris); 1993 Apr; 41(4):379-84. PubMed ID: 8233639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of three newer quinolones in pregnant and lactating women.
    Giamarellou H; Kolokythas E; Petrikkos G; Gazis J; Aravantinos D; Sfikakis P
    Am J Med; 1989 Nov; 87(5A):49S-51S. PubMed ID: 2589384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin].
    Soussy CJ; Deforges L; Le Van Thoi J; Duval J
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):759-67. PubMed ID: 3309811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of ofloxacin against Mycobacterium leprae in the mouse.
    Grosset JH; Guelpa-Lauras CC; Perani EG; Beoletto C
    Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):259-64. PubMed ID: 3045223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel in silico model to predict corneal permeability for congeneric drugs: a QSPR approach.
    Sharma C; Velpandian T; Biswas NR; Nayak N; Vajpayee RB; Ghose S
    J Biomed Biotechnol; 2011; 2011():483869. PubMed ID: 21403901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of pefloxacin and its metabolite norfloxacin in male and female ducks.
    Dimitrova D; Moutafchieva R; Kanelov I; Dinev T; Yanev S; Pandova B; Lashev L
    J Vet Pharmacol Ther; 2008 Apr; 31(2):167-70. PubMed ID: 18307509
    [No Abstract]   [Full Text] [Related]  

  • 14. Stereoselectivity of ofloxacin intestinal transport in the rat.
    Rabbaa L; Dautrey S; Colas-Linhart N; Carbon C; Farinotti R
    Drugs; 1995; 49 Suppl 2():333-4. PubMed ID: 8549352
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of ofloxacin in broiler chicken.
    Kalaiselvi L; Sriranjani D; Ramesh S; Sriram P; Mathuram LN
    J Vet Pharmacol Ther; 2006 Jun; 29(3):185-9. PubMed ID: 16669862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro kinetics of the activity of fusidic acid and fluoroquinolones combinations against staphylococci according to methicillin-resistance phenotype. Implications for the treatment of osteoarticular infections].
    Reynaud AE; Espaze EP; Coste-Burel M; Richet H
    Pathol Biol (Paris); 1992 May; 40(5):466-70. PubMed ID: 1495828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of anxiogenic effects of fluoroquinolones in rats.
    Prabhu S; Rewari S
    Indian J Physiol Pharmacol; 1998 Jan; 42(1):135-8. PubMed ID: 9513807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fluoroquinolones in clinical practice. Pefloxacin (abaktal, peflacine)].
    Fomina IP; Iudin SM; Kashina LB
    Antibiot Khimioter; 1995; 40(11-12):70-7. PubMed ID: 8830644
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
    Periti P; Mazzei T; Nicoletti P
    Chemioterapia; 1987 Apr; 6(2):75-8. PubMed ID: 3474081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy.
    Shandil RK; Jayaram R; Kaur P; Gaonkar S; Suresh BL; Mahesh BN; Jayashree R; Nandi V; Bharath S; Balasubramanian V
    Antimicrob Agents Chemother; 2007 Feb; 51(2):576-82. PubMed ID: 17145798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.